These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15711437)

  • 1. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Roukas DK; Christodoulou GN
    Clin Neuropharmacol; 2005; 28(1):50-3. PubMed ID: 15711437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Roukas DK
    Eur Psychiatry; 2005 Aug; 20(5-6):409-15. PubMed ID: 16171655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine resistance: augmentation strategies.
    Porcelli S; Balzarro B; Serretti A
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.
    Weiner E; Conley RR; Ball MP; Feldman S; Gold JM; Kelly DL; Wonodi I; McMahon RP; Buchanan RW
    Neuropsychopharmacology; 2010 Oct; 35(11):2274-83. PubMed ID: 20664583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
    Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
    Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.
    Lindenmayer JP; Iskander A; Park M; Apergi FS; Czobor P; Smith R; Allen D
    J Clin Psychiatry; 1998 Oct; 59(10):521-7. PubMed ID: 9818633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
    J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
    Small JG; Klapper MH; Malloy FW; Steadman TM
    J Clin Psychopharmacol; 2003 Jun; 23(3):223-8. PubMed ID: 12826983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
    Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
    Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.